MYLAN LABORATORIES INC (MYL) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1000 transactions totaling $2.2B, demonstrating a bearish sentiment with -$2.2B in net insider flow. The most recent transaction on Nov 16, 2020 involved a transaction of 9,440 shares valued at $0.
No significant insider buying has been recorded for MYL in the recent period.
No significant insider selling has been recorded for MYL in the recent period.
Based on recent SEC filings, insider sentiment for MYL is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.2B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MYLAN LABORATORIES INC (MYL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading MYL stock, having executed 1000 transactions in the past 90 days. The most active insider is Investments Luxembourg S.a R.l. Abbott (Executive), who has made 2 transactions totaling $2.3B.
Get notified when executives and directors at MYL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 16, 2020 | S. Vollebregt Sjoerd | Executive | Option Exercise | 9,440 | $N/A | $0 | |
| Nov 16, 2020 | S. Vollebregt Sjoerd | Executive | Disposition | 57,709 | $N/A | $0 | |
| Nov 16, 2020 | Meer Mohr Pauline Van Der | Executive | Disposition | 6,265 | $N/A | $0 | |
| Nov 16, 2020 | A. Mark Richard | Executive | Disposition | 9,228 | $N/A | $0 | |
| Nov 16, 2020 | Korman Harry | Executive | Disposition | 26,515 | $N/A | $0 | |
| Nov 16, 2020 | L. Vanderveen Randall | Executive | Disposition | 57,227 | $N/A | $0 | |
| Nov 16, 2020 | L. Vanderveen Randall | Executive | Option Exercise | 9,440 | $N/A | $0 | |
| Nov 16, 2020 | Malik Rajiv | Executive | Disposition | 88,365 | $N/A | $0 | |
| Nov 16, 2020 | Malik Rajiv | Executive | Disposition | 459,699 | $N/A | $0 | |
| Nov 16, 2020 | E. Higgins Melina | Executive | Disposition | 74,000 | $N/A | $0 | |
| Nov 16, 2020 | E. Higgins Melina | Executive | Disposition | 39,131 | $N/A | $0 | |
| Nov 16, 2020 | F. Dimick Neil | Executive | Disposition | 51,263 | $N/A | $0 | |
| Nov 16, 2020 | Mauro Anthony | Executive | Disposition | 119,305 | $N/A | $0 | |
| Nov 16, 2020 | Mauro Anthony | Executive | Disposition | 5,574 | $N/A | $0 | |
| Nov 16, 2020 | Joellen Lyons Dillon | Executive | Disposition | 15,609 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 168 | $2.2B | 46.1% |
Other(J) | 1 | $2.0B | 42.1% |
Exercise (Options)(X) | 17 | $299.3M | 6.3% |
Exercise(M) | 478 | $153.1M | 3.2% |
Payment(F) | 227 | $91.1M | 1.9% |
Disposition(D) | 45 | $7.4M | 0.2% |
Purchase(P) | 21 | $6.8M | 0.1% |
Gift(G) | 19 | $0 | 0.0% |
Award(A) | 24 | $0 | 0.0% |
Insider selling pressure at MYLAN LABORATORIES INC has increased, with 26 insiders executing 1000 transactions across all time. Total sales of $2.2B significantly outpace purchases of $6.8M, resulting in a net outflow of $2.2B. This selling activity appears largely discretionary, which may warrant closer attention from investors.